Prospective, Longitudinal, Non-Interventional study of Disease Burden and treatment of patients with low-risk Myelofibrosis or High-Risk Essential Thrombocythemia or ET Receving ET- Directed Therapy

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Prospective, Longitudinal, Non-Interventional study of Disease Burden and treatment of patients with low-risk Myelofibrosis or High-Risk Essential Thrombocythemia or ET Receving ET- Directed Therapy

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.